About Healthcare Professionals Patients News Join Us Investor Relations Contact Us


Explore our latest news
19 Aug,2022
Zylox-Tonbridge maintains strong revenue and gross profit growth, including gross margin improvement driven by its platform-based strategy in 1H22

On August 15, Zylox-Tonbridge (2190.HK, “the Company”) released its 2022 interim results.

25 Apr,2022
Tonbridge Webinar:BGC in Transradial Neurointerventions

Chinese channal:https://live.hh-medic.com/liveview/1251English channal:https://live.hh-medic.com/liveview/1252

12 Apr,2022
Zylox-Tonbridge: PTA Balloon Catheter — Large Diameter Obtains Marketing Approval from NMPA

On April12, Zylox-Tonbridge (2190.HK, “the Company”) announced its PTA Balloon Catheter-Large Diameter, a product independently developed by the Company, has been granted the marketing approval by t...

21 Mar,2022
Zylox-Tonbridge: Approval for Commercialization of Multiple Products Enabled 544% Year-on-year Revenue Growth for the Company in 2021

Zylox-Tonbridge (2190.HK, hereinafter called "the Company") announced on March 15 its first fiscal-year financial report since its IPO on Hong Kong Stock Exchange.The Company reported an ope...

02 Mar,2022
Approval Granted for Full Circulation of Zylox-Tonbridge H shares, Significantly Raising its Circulation Market Capitalization

Zylox-Tonbridge Medical Technology Co., Ltd. ("Zylox-Tonbridge" or "the Company", "2190.HK") announced on February 28 that it has received approval from Hong Kong Stock E...

25 Jan,2022
Zylox-Tonbridge's strategic investment in Wire Sciences boosts the development of innovative vascular intervention surgical robots

On January 17, Zylox-Tonbridge (2190.HK, “the Company”) announced the completion of its strategic investment in Wire Sciences Medical Technology(Suzhou)Co., Ltd. (“Wire Sciences”). By leveraging its own s...

Zylox-Tonbridge Medical